Filing Details
- Accession Number:
- 0001209191-17-050554
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-29 17:12:22
- Reporting Period:
- 2017-08-25
- Accepted Time:
- 2017-08-29 16:12:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 786947 | Acura Pharmaceuticals Inc | ACUR | Pharmaceutical Preparations (2834) | 110853640 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1455740 | W Albert Brzeczko | C/O Acura Pharmaceuticals, Inc. 616 N North Court Palatine IL 60067 | Vp Technical Affairs - Apt | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-25 | 1,000 | $0.48 | 6,200 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-25 | 1,000 | $0.48 | 7,200 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-25 | 1,000 | $0.48 | 8,200 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-25 | 1,800 | $0.48 | 10,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-28 | 2,000 | $0.45 | 12,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-29 | 2,000 | $0.47 | 14,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-29 | 1,000 | $0.47 | 15,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-29 | 1,000 | $0.47 | 16,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
